---
title: Chronic Kidney Disease (CKD)
author: J. Austin Straley, DO
date: 2024-03-16
categories: 
    - Nephrology
---

- [ADVANCE: Intensive glycemic control (â‰¤180) reduces risk of nephropathy][1]
- [CHOIR: Treating to a lower Hgb target with EPO reduced MI/Death/CHF/Stroke in Anemia with CKD; no conferred survival with target >13][2]
- [RENAAL: In T2DM and Nephropathy, Losartan 50-100 reduced ESRD risk][3]
- [IDEAL: Early vs. Late Dialysis in CKD; No survival difference][4]

[1]: https://www.nejm.org/doi/full/10.1056/nejmoa0802987
[2]: https://pubmed.ncbi.nlm.nih.gov/17108343/{:target="_blank"}
[3]: https://pubmed.ncbi.nlm.nih.gov/11565518/{:target="_blank"}
[4]: https://pubmed.ncbi.nlm.nih.gov/20581422/{:target="_blank"}
